Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure
Open accessThe DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Abstract
Heart failure exhibits remarkable pathophysiologic heterogeneity. A large body of evidence suggests that regardless of the underlying etiology, heart failure is associated with induction of cytokines and chemokines that may contribute to the pathogenesis of adverse remodeling, and systolic and diastolic dysfunction. The pro-inflammatory cytokines tumor necrosis factor (TNF)-α, interleukin (IL)-1, and IL-6 have been extensively implicated in the pathogenesis of heart failure. Inflammatory cytokines modulate phenotype and function of all myocardial cells, suppressing contractile function in cardiomyocytes, inducing inflammatory activation in macrophages, stimulating microvascular inflammation and dysfunction, and promoting a matrix-degrading phenotype in fibroblasts. Moreover, cytokine-induced growth factor synthesis may exert chronic fibrogenic actions contributing to the pathogenesis of heart failure with preserved ejection fraction (HFpEF). In addition to their role in adverse cardiac remodeling, some inflammatory cytokines may also exert protective actions on cardiomyocytes under conditions of stress. Chemokines, such as CCL2, are also upregulated in failing hearts and may stimulate recruitment of pro-inflammatory leukocytes, promoting myocardial injury, fibrotic remodeling, and dysfunction. Although experimental evidence suggests that cytokine and chemokine targeting may hold therapeutic promise in heart failure, clinical translation remains challenging. This review manuscript summarizes our knowledge on the role of TNF-α, IL-1, IL-6, and CCL2 in the pathogenesis of heart failure, and discusses the promises and challenges of targeted anti-cytokine therapy. Dissection of protective and maladaptive cellular actions of cytokines in the failing heart, and identification of patient subsets with overactive or dysregulated myocardial inflammatory responses are required for design of successful therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
Heart Disease: A Textbook of Cardiovascular Medicine.
(1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-3-415_3 · Cited by 4,109
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582
Overview of the IL ‐1 family in innate inflammation and acquired immunity
Dinarello, C. A. (2018) · Immunological Reviews · doi:10.1111/imr.12621 · Cited by 1,866
The inflammatory response in myocardial injury, repair, and remodelling
Frangogiannis, N. G. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.28 · Cited by 1,738
Self-citationChung, E. S., Packer, M., Lo, K. H., Fasanmade, A. A., & Willerson, J. T. (2003) · Circulation · doi:10.1161/01.cir.0000077913.60364.d2 · Cited by 1,644
Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric Oxide
Finkel, M. S., Oddis, C. V., Jacob, T. D., Watkins, S. C., Hattler, B. G., & Simmons, R. L. (1992) · Science · doi:10.1126/science.1631560 · Cited by 1,628
Mann, D. L., McMurray, J. J. V., Packer, M., Swedberg, K., Borer, J. S., Colucci, W. S., Djian, J., Drexler, H., Feldman, A., Kober, L., et al. (2004) · Circulation · doi:10.1161/01.cir.0000124490.27666.b2 · Cited by 1,240
Senni, M., Tribouilloy, C. M., Rodeheffer, R. J., Jacobsen, S. J., Evans, J. M., Bailey, K. R., & Redfield, M. M. (1998) · Circulation · doi:10.1161/01.cir.98.21.2282 · Cited by 1,088
Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart
Torre-Amione, G., Kapadia, S., Lee, J., Durand, J.-B., Bies, R. D., Young, J. B., & Mann, D. L. (1996) · Circulation · doi:10.1161/01.cir.93.4.704 · Cited by 989
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892
Kawaguchi, M., Takahashi, M., Hata, T., Kashima, Y., Usui, F., Morimoto, H., Izawa, A., Takahashi, Y., Masumoto, J., Koyama, J., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.982777 · Cited by 884
The Chemokine System in Innate Immunity
Sokol, C. L., & Luster, A. D. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016303 · Cited by 862
Therapeutic siRNA silencing in inflammatory monocytes in mice
Leuschner, F., Dutta, P., Gorbatov, R., Novobrantseva, T. I., Donahoe, J. S., Courties, G., Lee, K. M., Kim, J. I., Markmann, J. F., Marinelli, B., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1989 · Cited by 839
Heart Failure With Preserved Ejection Fraction In Perspective
Pfeffer, M. A., Shah, A. M., & Borlaug, B. A. (2019) · Circulation Research · doi:10.1161/circresaha.119.313572 · Cited by 837
Kubota, T., McTiernan, C. F., Frye, C. S., Slawson, S. E., Lemster, B. H., Koretsky, A. P., Demetris, A. J., & Feldman, A. M. (1997) · Circulation Research · doi:10.1161/01.res.81.4.627 · Cited by 829
Interleukin-6 Family Cytokines
Rose-John, S. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028415 · Cited by 799
Kumar, A., Thota, V, Dee, L., Olson, J., Uretz, E., & Parrillo, J. E. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.949 · Cited by 791
Reappraising the role of inflammation in heart failure
Adamo, L., Rocha-Resende, C., Prabhu, S. D., & Mann, D. L. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0315-x · Cited by 765
Bajpai, G., Bredemeyer, A., Li, W., Zaitsev, K., Koenig, A. L., Lokshina, I., Mohan, J., Ivey, B., Hsiao, H.-M., Weinheimer, C., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.314028 · Cited by 751
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
Abbate, A., Toldo, S., Marchetti, C., Kron, J., Van Tassell, B. W., & Dinarello, C. A. (2020) · Circulation Research · doi:10.1161/circresaha.120.315937 · Cited by 730
Mauer, J., Chaurasia, B., Goldau, J., Vogt, M. C., Ruud, J., Nguyen, K. D., Theurich, S., Hausen, A. C., Schmitz, J., Brönneke, H. S., et al. (2014) · Nature Immunology · doi:10.1038/ni.2865 · Cited by 727
Dewald, O., Zymek, P., Winkelmann, K., Koerting, A., Ren, G., Abou-Khamis, T., Michael, L. H., Rollins, B. J., Entman, M. L., & Frangogiannis, N. G. (2005) · Circulation Research · doi:10.1161/01.res.0000163017.13772.3a · Cited by 719
Self-citationYokoyama, T., Vaca, L., Rossen, R. D., Durante, W., Hazarika, P., & Mann, D. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116834 · Cited by 717
Chronic Heart Failure and Inflammation: What Do We Really Know?
Dick, S. A., & Epelman, S. (2016) · Circulation Research · doi:10.1161/circresaha.116.308030 · Cited by 692
Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure
Everett, B. M., Cornel, J. H., Lainscak, M., Anker, S. D., Abbate, A., Thuren, T., Libby, P., Glynn, R. J., & Ridker, P. M. (2019) · Circulation · doi:10.1161/circulationaha.118.038010 · Cited by 658
Resident fibroblast lineages mediate pressure overload–induced cardiac fibrosis
Moore-Morris, T., Guimarães-Camboa, N., Banerjee, I., Zambon, A. C., Kisseleva, T., Velayoudon, A., Stallcup, W. B., Gu, Y., Dalton, N. D., Cedenilla, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74783 · Cited by 630
Mezzaroma, E., Toldo, S., Farkas, D., Seropian, I. M., Van Tassell, B. W., Salloum, F. N., Kannan, H. R., Menna, A. C., Voelkel, N. F., & Abbate, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108586108 · Cited by 629
Cardiac Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis Factor-α
Bryant, D., Becker, L., Richardson, J., Shelton, J., Franco, F., Peshock, R., Thompson, M., & Giroir, B. (1998) · Circulation · doi:10.1161/01.cir.97.14.1375 · Cited by 600
The Extracellular Matrix in Ischemic and Nonischemic Heart Failure
Frangogiannis, N. G. (2019) · Circulation Research · doi:10.1161/circresaha.119.311148 · Cited by 520
Self-citationSiwik, D. A., Chang, D. L.-F., & Colucci, W. S. (2000) · Circulation Research · doi:10.1161/01.res.86.12.1259 · Cited by 517
Frangogiannis, N. G., Lindsey, M. L., Michael, L. H., Youker, K. A., Bressler, R. B., Mendoza, L. H., Spengler, R. N., Smith, C. W., & Entman, M. L. (1998) · Circulation · doi:10.1161/01.cir.98.7.699 · Cited by 511
Self-citationInterleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness.
Gulick, T., Chung, M. K., Pieper, S. J., Lange, L. G., & Schreiner, G. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6753 · Cited by 496
Meléndez, G. C., McLarty, J. L., Levick, S. P., Du, Y., Janicki, J. S., & Brower, G. L. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.148635 · Cited by 442
Kurrelmeyer, K. M., Michael, L. H., Baumgarten, G., Taffet, G. E., Peschon, J. J., Sivasubramanian, N., Entman, M. L., & Mann, D. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070036297 · Cited by 440
Kapadia, S., Lee, J., Torre-Amione, G., Birdsall, H. H., Ma, T. S., & Mann, D. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118090 · Cited by 437
Gharaee-Kermani, M., Denholm, E. M., & Phan, S. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17779 · Cited by 435
NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model
Luo, B., Li, B., Wang, W., Liu, X., Xia, Y., Zhang, C., Zhang, M., Zhang, Y., & An, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104771 · Cited by 408
Recent Advances in Chemokines and Chemokine Receptors
Zlotnik, A., Morales, J., & Hedrick, J. A. (1999) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v19.i1.10 · Cited by 407
Kleveland, O., Kunszt, G., Bratlie, M., Ueland, T., Broch, K., Holte, E., Michelsen, A. E., Bendz, B., Amundsen, B. H., Espevik, T., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw171 · Cited by 400
Deswal, A., Bozkurt, B., Seta, Y., Parilti-Eiswirth, S., Hayes, F. A., Blosch, C., & Mann, D. L. (1999) · Circulation · doi:10.1161/01.cir.99.25.3224 · Cited by 393
Sun, M., Chen, M., Dawood, F., Zurawska, U., Li, J. Y., Parker, T., Kassiri, Z., Kirshenbaum, L. A., Arnold, M., Khokha, R., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.643585 · Cited by 383
Dewald, O., Ren, G., Duerr, G. D., Zoerlein, M., Klemm, C., Gersch, C., Tincey, S., Michael, L. H., Entman, M. L., & Frangogiannis, N. G. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63154-9 · Cited by 382
Self-citationSivasubramanian, N., Coker, M. L., Kurrelmeyer, K. M., MacLellan, W. R., DeMayo, F. J., Spinale, F. G., & Mann, D. L. (2001) · Circulation · doi:10.1161/hc3401.093154 · Cited by 382
Ratziu, V., Sanyal, A., Harrison, S. A., Wong, V. W., Francque, S., Goodman, Z., Aithal, G. P., Kowdley, K. V., Seyedkazemi, S., Fischer, L., et al. (2020) · Hepatology · doi:10.1002/hep.31108 · Cited by 378
Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins
Mackiewicz, A., Schooltink, H., Heinrich, P. C., & Rose-John, S. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.6.2021 · Cited by 370
Interleukin-1 Receptor Type I Signaling Critically Regulates Infarct Healing and Cardiac Remodeling
Bujak, M., Dobaczewski, M., Chatila, K., Mendoza, L. H., Li, N., Reddy, A., & Frangogiannis, N. G. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070974 · Cited by 365
Self-citationStructure-activity relationships of chemokines
Clark-Lewis, I., Kim, K.-S., Rajarathnam, K., Gong, J.-H., Dewald, B., Moser, B., Baggiolini, M., & Sykes, B. D. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.5.703 · Cited by 361
Abbate, A., Salloum, F. N., Vecile, E., Das, A., Hoke, N. N., Straino, S., Biondi-Zoccai, G. G. L., Houser, J.-E., Qureshi, I. Z., Ownby, E. D., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.740233 · Cited by 360
Gwechenberger, M., Mendoza, L. H., Youker, K. A., Frangogiannis, N. G., Smith, C. W., Michael, L. H., & Entman, M. L. (1999) · Circulation · doi:10.1161/01.cir.99.4.546 · Cited by 342
Self-citationBone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice
Haudek, S. B., Xia, Y., Huebener, P., Lee, J. M., Carlson, S., Crawford, J. R., Pilling, D., Gomer, R. H., Trial, J., Frangogiannis, N. G., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608799103 · Cited by 338
Self-citationLi, Y. Y., Feng, Y. Q., Kadokami, T., McTiernan, C. F., Draviam, R., Watkins, S. C., & Feldman, A. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12746 · Cited by 324
Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis)
Scholz, D., Ito, W., Fleming, I., Deindl, E., Sauer, A., Wiesnet, M., Busse, R., Schaper, J., & Schaper, W. (2000) · Virchows Archiv · doi:10.1007/s004280050039 · Cited by 309
The role of IL-1 in the pathogenesis of heart disease
Bujak, M., & Frangogiannis, N. G. (2009) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-009-0024-y · Cited by 307
Self-citationIkonomidis, I., Lekakis, J. P., Nikolaou, M., Paraskevaidis, I., Andreadou, I., Kaplanoglou, T., Katsimbri, P., Skarantavos, G., Soucacos, P. N., & Kremastinos, D. T. (2008) · Circulation · doi:10.1161/circulationaha.107.731877 · Cited by 307
Suetomi, T., Willeford, A., Brand, C. S., Cho, Y., Ross, R. S., Miyamoto, S., & Brown, J. H. (2018) · Circulation · doi:10.1161/circulationaha.118.034621 · Cited by 304
Dobaczewski, M., Xia, Y., Bujak, M., Gonzalez-Quesada, C., & Frangogiannis, N. G. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090759 · Cited by 301
Self-citationPatel, B., Bansal, S. S., Ismahil, M. A., Hamid, T., Rokosh, G., Mack, M., & Prabhu, S. D. (2018) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2017.12.006 · Cited by 297
Myocardial and Systemic Inflammation in Acute Stress-Induced (Takotsubo) Cardiomyopathy
Scally, C., Abbas, H., Ahearn, T., Srinivasan, J., Mezincescu, A., Rudd, A., Spath, N., Yucel-Finn, A., Yuecel, R., Oldroyd, K., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.037975 · Cited by 297
Inflammatory Cardiomyopathic Syndromes
Trachtenberg, B. H., & Hare, J. M. (2017) · Circulation Research · doi:10.1161/circresaha.117.310221 · Cited by 289
Frangogiannis, N. G., Dewald, O., Xia, Y., Ren, G., Haudek, S., Leucker, T., Kraemer, D., Taffet, G., Rollins, B. J., & Entman, M. L. (2007) · Circulation · doi:10.1161/circulationaha.106.646091 · Cited by 289
Self-citationKapadia, S. R., Oral, H., Lee, J., Nakano, M., Taffet, G. E., & Mann, D. L. (1997) · Circulation Research · doi:10.1161/01.res.81.2.187 · Cited by 289
Hypertensive Myocardial Fibrosis and Diastolic Dysfunction: Another Model of Inflammation?
Kuwahara, F., Kai, H., Tokuda, K., Takeya, M., Takeshita, A., Egashira, K., & Imaizumi, T. (2004) · Hypertension · doi:10.1161/01.hyp.0000118584.33350.7d · Cited by 282
Modulation of Cytokine-Induced Cardiac Myocyte Apoptosis by Nitric Oxide, Bak, and Bcl-x
Ing, D. J., Zang, J., Dzau, V. J., Webster, K. A., & Bishopric, N. H. (1999) · Circulation Research · doi:10.1161/01.res.84.1.21 · Cited by 282
Pagani, F. D., Baker, L. S., Hsi, C., Knox, M., Fink, M. P., & Visner, M. S. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115873 · Cited by 278
Haudek, S. B., Taffet, G. E., Schneider, M. D., & Mann, D. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29134 · Cited by 278
Hamid, T., Gu, Y., Ortines, R. V., Bhattacharya, C., Wang, G., Xuan, Y.-T., & Prabhu, S. D. (2009) · Circulation · doi:10.1161/circulationaha.108.802918 · Cited by 274
Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic
Jabri, A., Kalra, A., Kumar, A., Alameh, A., Adroja, S., Bashir, H., Nowacki, A. S., Shah, R., Khubber, S., Kanaa’N, A., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.14780 · Cited by 271
Xia, Y., Lee, K., Li, N., Corbett, D., Mendoza, L., & Frangogiannis, N. G. (2009) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0541-5 · Cited by 264
Self-citationZhou, L., Azfer, A., Niu, J., Graham, S., Choudhury, M., Adamski, F. M., Younce, C., Binkley, P. F., & Kolattukudy, P. E. (2006) · Circulation Research · doi:10.1161/01.res.0000220106.64661.71 · Cited by 260
Sanders-van Wijk, S., van Empel, V., Davarzani, N., Maeder, M. T., Handschin, R., Pfisterer, M. E., Brunner-La Rocca, H. P., & for the TIME-CHF investigators (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.414 · Cited by 258
Kraakman, M. J., Kammoun, H. L., Allen, T. L., Deswaerte, V., Henstridge, D. C., Estevez, E., Matthews, V. B., Neill, B., White, D. A., Murphy, A. J., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.02.006 · Cited by 257
Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction
Sager, H. B., Heidt, T., Hulsmans, M., Dutta, P., Courties, G., Sebas, M., Wojtkiewicz, G. R., Tricot, B., Iwamoto, Y., Sun, Y., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016160 · Cited by 253
Saxena, A., Chen, W., Su, Y., Rai, V., Uche, O. U., Li, N., & Frangogiannis, N. G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300725 · Cited by 252
Self-citationZhao, L., Cheng, G., Jin, R., Afzal, M. R., Samanta, A., Xuan, Y.-T., Girgis, M., Elias, H. K., Zhu, Y., Davani, A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.308688 · Cited by 251
Yamamoto, T., Eckes, B., Mauch, C., Hartmann, K., & Krieg, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6174 · Cited by 250
Hayashidani, S., Tsutsui, H., Shiomi, T., Ikeuchi, M., Matsusaka, H., Suematsu, N., Wen, J., Egashira, K., & Takeshita, A. (2003) · Circulation · doi:10.1161/01.cir.0000092890.29552.22 · Cited by 240
Activation of gp130 Transduces Hypertrophic Signals via STAT3 in Cardiac Myocytes
Kunisada, K., Tone, E., Fujio, Y., Matsui, H., Yamauchi-Takihara, K., & Kishimoto, T. (1998) · Circulation · doi:10.1161/01.cir.98.4.346 · Cited by 237
Vergunst, C. E., Gerlag, D. M., Lopatinskaya, L., Klareskog, L., Smith, M. D., van den Bosch, F., Dinant, H. J., Lee, Y., Wyant, T., Jacobson, E. W., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23591 · Cited by 236
Sano, M., Fukuda, K., Kodama, H., Pan, J., Saito, M., Matsuzaki, J., Takahashi, T., Makino, S., Kato, T., & Ogawa, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003128200 · Cited by 233
Chirinos, J. A., Orlenko, A., Zhao, L., Basso, M. D., Cvijic, M. E., Li, Z., Spires, T. E., Yarde, M., Wang, Z., Seiffert, D. A., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.069 · Cited by 216
IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction: Results From DHART2
Van Tassell, B. W., Trankle, C. R., Canada, J. M., Carbone, S., Buckley, L., Kadariya, D., Del Buono, M. G., Billingsley, H., Wohlford, G., Viscusi, M., et al. (2018) · Circulation: Heart Failure · doi:10.1161/circheartfailure.118.005036 · Cited by 213
Targeting inflammatory pathways in myocardial infarction
Christia, P., & Frangogiannis, N. G. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12118 · Cited by 207
Self-citationMark, K. S., Trickler, W. J., & Miller, D. W. (2001) · PubMed · Cited by 197
Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle.
Kolattukudy, P. E., Quach, T., Bergese, S. D., Breckenridge, S. M., Hensley, J., Altschuld, R. A., Gordillo, G. M., Klenotic, S. M., Orosz, C. G., & Parker‐Thornburg, J. (1998) · Europe PMC (PubMed Central) · Cited by 195
Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy
Haudek, S. B., Cheng, J., Du, J., Wang, Y., Hermosillo-Rodriguez, J., Trial, J., Taffet, G. E., & Entman, M. L. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.05.005 · Cited by 190
Bracey, N. A., Beck, P. L., Muruve, D. A., Hirota, S. A., Guo, J., Jabagi, H., Wright Jr, J. R., MacDonald, J. A., Lees‐Miller, J. P., Roach, D., et al. (2013) · Experimental Physiology · doi:10.1113/expphysiol.2012.068338 · Cited by 188
Tumor Necrosis Factor-α and Mortality in Heart Failure: A Community Study
Dunlay, S. M., Weston, S. A., Redfield, M. M., Killian, J. M., & Roger, V. L. (2008) · Circulation · doi:10.1161/circulationaha.107.759191 · Cited by 186
Kinugawa, K., Takahashi, T., Kohmoto, O., Yao, A., Aoyagi, T., Momomura, S., Hirata, Y., & Serizawa, T. (1994) · Circulation Research · doi:10.1161/01.res.75.2.285 · Cited by 178
Persistent Expression of Cytokine in the Chronic Stage of Viral Myocarditis in Mice
Shioi, T., Matsumori, A., & Sasayama, S. (1996) · Circulation · doi:10.1161/01.cir.94.11.2930 · Cited by 173
Obesity-Related Heart Failure With a Preserved Ejection Fraction
Packer, M., & Kitzman, D. W. (2018) · JACC: Heart Failure · doi:10.1016/j.jchf.2018.01.009 · Cited by 172
Hilfiker-Kleiner, D., Shukla, P., Klein, G., Schaefer, A., Stapel, B., Hoch, M., Müller, W., Scherr, M., Theilmeier, G., Ernst, M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.933127 · Cited by 167
Shioi, T., Matsumori, A., Kihara, Y., Inoko, M., Ono, K., Iwanaga, Y., Yamada, T., Iwasaki, A., Matsushima, K., & Sasayama, S. (1997) · Circulation Research · doi:10.1161/01.res.81.5.664 · Cited by 162
TetsuoShioi, AkiraMatsumori, YasukiKihara, MoriakiInoko, KohOno, YoshitakaIwanaga, TakehikoYamada, AtsushiIwasaki, KoujiMatsushima, & ShigetakeSasayama (1997) · Circulation Research · Cited by 162
Eriksson, U., Kurrer, M. O., Sonderegger, I., Iezzi, G., Tafuri, A., Hunziker, L., Suzuki, S., Bachmaier, K., Bingisser, R. M., Penninger, J. M., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021788 · Cited by 158
Mir, S. A., Chatterjee, A., Mitra, A., Pathak, K., Mahata, S. K., & Sarkar, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.246173 · Cited by 157
Honsho, S., Nishikawa, S., Amano, K., Zen, K., Adachi, Y., Kishita, E., Matsui, A., Katsume, A., Yamaguchi, S., Nishikawa, K., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.208199 · Cited by 156
Smart, N., Mojet, M. H., Latchman, D. S., Marber, M. S., Duchen, M. R., & Heads, R. J. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.08.017 · Cited by 142
Interleukin-1 in Myocardium and Coronary Arteries of Patients with Dilated Cardiomyopathy
Francis, S., Holden, H. M., Holt, C. M., & Duff, G. W. (1998) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1997.0592 · Cited by 141
Kobara, M., Noda, K., Kitamura, M., Okamoto, A., Shiraishi, T., Toba, H., Matsubara, H., & Nakata, T. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq078 · Cited by 135
Kruglov, E. A., Nathanson, R. A., Nguyễn, T. T., & Dranoff, J. A. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00308.2005 · Cited by 132
Wilson, H. M., Cheyne, L., Brown, P. A., Kerr, K. M., Hannah, A., Srinivasan, J., Duniak, N., Horgan, G. W., & Dawson, D. K. (2018) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2018.08.006 · Cited by 132
Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure
Yue, P., Massie, B. M., Simpson, P. C., & Long, C. S. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.275.1.h250 · Cited by 131
Dewald, O., Frangogiannis, N. G., Zoerlein, M., Duerr, G. D., Klemm, C., Knuefermann, P., Taffet, G. E., Michael, L. H., Crapo, J. D., Welz, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438035100 · Cited by 130
Self-citationKubota, T., Miyagishima, M., Alvarez, R., Kormos, R. L., Rosenblum, W. D., Demetris, A. J., Semigran, M. J., Dec, G. W., Holubkov, R., McTiernan, C. F., et al. (2000) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(00)00173-x · Cited by 130
Baumgarten, G., Knuefermann, P., Kalra, D. K., Gao, F., Taffet, G. E., Michael, L., Blackshear, P. J., Carballo, E., Sivasubramanian, N., & Mann, D. L. (2002) · Circulation · doi:10.1161/01.cir.0000015608.37608.18 · Cited by 127
Tumor necrosis factor-α confers cardioprotection through ectopic expression of keratins K8 and K18
Papathanasiou, S., Rickelt, S., Soriano, M. E., Schips, T. G., Maier, H. J., Davos, C. H., Varela, A., Kaklamanis, L., Mann, D. L., & Capetanaki, Y. (2015) · Nature Medicine · doi:10.1038/nm.3925 · Cited by 117
IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis
Chou, C., Hung, C., Liao, C., Wei, L., Chen, C., Shun, C., Wen, W.-F., Wan, C., Wu, X.-M., Chang, Y., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy013 · Cited by 116
Behr, T. M., Wang, X., Aiyar, N. V., Coatney, R. W., Li, X., Koster, P. D., Angermann, C. E., Ohlstein, E. H., Feuerstein, G., & Winaver, J. M. (2000) · Circulation · doi:10.1161/01.cir.102.11.1315 · Cited by 115
Chemokines in Myocardial Infarction
Chen, B., & Frangogiannis, N. G. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-10006-7 · Cited by 105
Self-citationActivity of interleukin 6 in the differentiation of monocytes to macrophages and dendritic cells
Mitani, H., Katayama, N., Araki, H., Ohishi, K., Kobayashi, K., Suzuki, H., Nishii, K., Masuya, M., Yasukawa, K., Minami, N., et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02020.x · Cited by 99
Cytokine-binding proteins: stimulating antagonists
Klein, B., & Brailly, H. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80161-8 · Cited by 99
MCP-1/CCL2 as a Therapeutic Target in Myocardial Infarction and Ischemic Cardiomyopathy
Xia, Y., & Frangogiannis, N. G. (2007) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152807780832265 · Cited by 96
Self-citationRegnase-1, a rapid response ribonuclease regulating inflammation and stress responses
Mao, R., Yang, R., Chen, X., Harhaj, E. W., Wang, X., & Fan, Y. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.70 · Cited by 93
Evidence for an Active Inflammatory Process in the Hibernating Human Myocardium
Frangogiannis, N. G., Shimoni, S., Chang, S. M., Ren, G., Shan, K., Aggeli, C., Reardon, M. J., Letsou, G. V., Espada, R., Ramchandani, M. K., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62568-0 · Cited by 91
Self-citationMATTILA, P., Majuri, M., MATTILA, P. S., & Renkonen, R. (1992) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1992.tb03087.x · Cited by 90
The interleukin-6/interleukin-6-receptorsystem is activated in donor hearts
Plenz, G. A. M., Eschert, H., Erren, M., Wichter, T., Böhm, M., Flesch, M., Scheld, H. H., & Deng, M. C.-H. K. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01791-6 · Cited by 90
Ikonomidis, I., Tzortzis, S., Lekakis, J., PARASKEVAIDIS, I. A., Andreadou, I., Nikolaou, M., Kaplanoglou, T., Katsimbri, P., Skarantavos, G., Soucacos, P. N., et al. (2009) · Heart · doi:10.1136/hrt.2009.168971 · Cited by 88
Eiken, H. G., Øie, E., Damås, J. K., Yndestad, A., Bjerkeli, V., Aass, H., Simonsen, S., Geiran, O. R., Tønnessen, T., Christensen, G., et al. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00795.x · Cited by 88
MCP-1/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes
Sakai, N., Wada, T., Furuichi, K., Shimizu, K., Kokubo, S., Hara, A., Yamahana, J., Okumura, T., Matsushima, K., Yokoyama, H., et al. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0305127 · Cited by 87
Mark, K. S., Trickler, W. J., & Miller, D. W. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29632-4 · Cited by 87
TNF-α inhibition attenuates adverse myocardial remodeling in a rat model of volume overload
Jobe, L. J., Meléndez, G. C., Levick, S. P., Du, Y., Brower, G. L., & Janicki, J. S. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00442.2009 · Cited by 86
Wang, J., Seo, M. J., Deci, M. B., Weil, B. R., Canty, J. M., & Nguyen, J. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s178650 · Cited by 81
MCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen species
Morimoto, H., Hirose, M., Takahashi, M., Kawaguchi, M., Ise, H., Kolattukudy, P. E., Yamada, M., & Ikeda, U. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn035 · Cited by 80
Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-α
Janczewski, A. M., Kadokami, T., Lemster, B. H., Frye, C. S., McTiernan, C. F., & Feldman, A. M. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.0718.2001 · Cited by 79
Bageghni, S. A., Hemmings, K. E., Yuldasheva, N. Y., Maqbool, A., Gamboa-Esteves, F. O., Humphreys, N. E., Jackson, M. S., Denton, C. P., Francis, S., Porter, K. E., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.125074 · Cited by 79
Harouki, N., Nicol, L., Rémy‐Jouet, I., Henry, J., Dumesnil, A., Lejeune, A., Renet, S., Lockwood, F., Djerada, Z., Wecker, D., et al. (2017) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2017.06.005 · Cited by 78
Grisanti, L. A., Traynham, C. J., Repas, A. A., Gao, E., Koch, W. J., & Tilley, D. G. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611023114 · Cited by 76
Infarct Fibroblasts Do Not Derive from Bone Marrow Lineages
Moore-Morris, T., Cattaneo, P., Guimarães-Camboa, N., Bogomolovas, J., Cedenilla, M., Banerjee, I., Ricote, M., Kisseleva, T., Zhang, L., Gu, Y.-S., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.311490 · Cited by 75
Abernethy, A. D., Raza, S. S., Sun, J., Anstrom, K. J., Tracy, R. P., Steiner, J., VanBuren, P., & LeWinter, M. M. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007385 · Cited by 73
Zhu, J., Zhang, J., Xiang, D., Zhang, Z., Zhang, L., Wu, M., Zhu, S., Zhang, R., & Han, W. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.06.024 · Cited by 67
Role of CCR2 in the Development of Streptozotocin-Treated Diabetic Cardiomyopathy
Tan, X., Hu, L., Shu, Z., Chen, L., Li, X., Du, M., Sun, D., Mao, X., Deng, S., Huang, K., et al. (2019) · Diabetes · doi:10.2337/db18-1231 · Cited by 64
Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy
Zhao, L., & Fu, Z. (2018) · Journal of Immunology Research · doi:10.1155/2018/5301548 · Cited by 59
Lu, W., Xie, Z., Tang, Y. M., Bai, L., Yao, Y., Fu, C., & Ma, G. (2015) · Theranostics · doi:10.7150/thno.11517 · Cited by 54
TNFα protects cardiac mitochondria independently of its cell surface receptors
Lacerda, L., McCarthy, J., Mungly, S. F. K., Lynn, E. G., Sack, M. N., Opie, L. H., & Lecour, S. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0113-4 · Cited by 53
Sanders, D. B., Larson, D. F., Hunter, K., Gorman, M., & Yang, B. (2001) · Perfusion · doi:10.1177/026765910101600110 · Cited by 47
MCP-1 mediates ischemia-reperfusion-induced cardiomyocyte apoptosis via MCPIP1 and CaSR
Zhang, W., Zhu, T., Chen, L., Luo, W. F., & Chao, J. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00308.2019 · Cited by 43
Macrophage-modulating cytokines predict adverse outcome in heart failure
Hohensinner, P. J., Rychli, K., Zorn, G., Hülsmann, M., Berger, R., Mörtl, D., Richter, B., Huber, K., Wojta, J., Niessner, A., et al. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-06-0399 · Cited by 42
Kleveland, O., Ueland, T., Kunszt, G., Bratlie, M., Yndestad, A., Broch, K., Holte, E., Ryan, L., Amundsen, B. H., Bendz, B., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.04.136 · Cited by 39
Dissecting the role of myeloid and mesenchymal fibroblasts in age-dependent cardiac fibrosis
Trial, J., Heredia, C. P., Taffet, G. E., Entman, M. L., & Cieslik, K. A. (2017) · Basic Research in Cardiology · doi:10.1007/s00395-017-0623-4 · Cited by 37
Omiya, S., Omori, Y., Taneike, M., Murakawa, T., Ito, J., Tanada, Y., Nishida, K., Yamaguchi, O., Satoh, T., Shah, A. M., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044582 · Cited by 34
Yokoe, I., Kobayashi, H., Kobayashi, Y., Giles, J. T., Yoneyama, K., Kitamura, N., & Takei, M. (2018) · Scandinavian Journal of Rheumatology · doi:10.1080/03009742.2017.1418424 · Cited by 32
The Cellular Origin of Activated Fibroblasts in the Infarcted and Remodeling Myocardium
Alex, L., & Frangogiannis, N. G. (2018) · Circulation Research · doi:10.1161/circresaha.118.312654 · Cited by 26
Self-citationMechanism of cardioprotective action of TNF-alpha in the isolated rat heart.
Rathi, S. S., Xu, Y., & Dhalla, N. S. (2002) · PubMed · Cited by 21
Platelets contribute to enhanced MCP-1 levels in patients with chronic heart failure
Stumpf, C., Lehner, C., Raaz, D., Yılmaz, A., Anger, T., Daniel, W. G., & Garlichs, C. (2007) · Heart · doi:10.1136/hrt.2007.115006 · Cited by 19
Iwasaki, J., Nakamura, K., Matsubara, H., Nakamura, Y., Nishii, N., Banba, K., Murakami, M., Ohta‐Ogo, K., Kimura, H., Toh, N., et al. (2009) · Cardiovascular Pathology · doi:10.1016/j.carpath.2008.12.004 · Cited by 19
Myeloid cells require gp130 signaling for protective anti‐inflammatory functions during sepsis
Sackett, S. D., Otto, T., Mohs, A., Sander, L. E., Strauch, S., Streetz, K. L., Kroy, D. C., & Trautwein, C. (2019) · The FASEB Journal · doi:10.1096/fj.201802118r · Cited by 18
Cited by
Role of serum cytokines in the prediction of heart failure in patients with coronary artery disease
Hou, Q., Sun, Z., Zhao, L., Liu, Y., Zhang, J., Huang, J., Luo, Y., Xiao, Y., Hu, Z., & Shen, A. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14491 · Cited by 5
“lating evidence has shown that cytokines play key roles in the pathogenesis of HF, including adverse remodelling and dysfunction of heart contracts and diastole.(9,31) CCL2 is overexpressed in the failing hearts and promotes myocardial injury.”
Background
Metadata
- Authors
- Hanna, A., & Frangogiannis, N. G.
- Venue
- Cardiovascular Drugs and Therapy
- Published
- 2020-09-09
- Volume
- 34
- Issue
- 6
- Pages
- 849-863
- ISSN
- 0920-3206 (ISSN-L)
- 1573-7241
- OpenAlex
- W3086485795
- Cited by
- 418
- References
- 148
- FWCI
- 26.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.